» Articles » PMID: 39333571

Machine Learning- a New Paradigm in Nanoparticle-mediated Drug Delivery to Cancerous Tissues Through the Human Cardiovascular System Enhanced by Magnetic Field

Overview
Journal Sci Rep
Specialty Science
Date 2024 Sep 27
PMID 39333571
Authors
Affiliations
Soon will be listed here.
Abstract

Nanoparticle-mediated drug delivery offers a promising approach to targeted cancer therapy, leveraging the ability of nanoparticles to deliver therapeutic agents directly to cancerous tissues with minimal impact on surrounding healthy cells. The presence of these nanoparticles is governed by a concentration equation, which accounts for the diffusion, convection, and reaction of the nanoparticles with the blood components. It is well-known that whenever a disease or infection occurs in a human, in 80% of cases a rise in the concentration of hydrogen peroxide in the blood occurs. This is the reason why blood is assumed to contain hydrogen peroxide (in the present study), which is a biomarker of oxidative stress and inflammation. This study explores the integration of machine learning (ML) techniques into the optimization of drug delivery processes within the human cardiovascular system, focusing on the enhancement of these processes through the application of magnetic fields. By employing ML algorithms, we analyze and predict the behavior of nanoparticles as they navigate the complex fluid dynamics of the cardiovascular system, particularly under the influence of an external magnetic field. The predictive power of ML models enables the precise control of nanoparticle trajectories, optimizing their accumulation in cancerous tissues and improving the efficacy of the drug delivery system. The findings of this study demonstrate that ML-enhanced magnetic targeting can significantly enhance the precision and effectiveness of nanoparticle-mediated drug delivery, offering a new paradigm in cancer treatment strategies. This approach has the potential to revolutionize the field by providing personalized and highly efficient therapeutic solutions for cancer patients.

References
1.
Zhan W, Gedroyc W, Xu X . Mathematical modelling of drug transport and uptake in a realistic model of solid tumour. Protein Pept Lett. 2014; 21(11):1146-56. DOI: 10.2174/0929866521666140807115629. View

2.
Ali A, Bukhari Z, Umar M, Ismail M, Abbas Z . Cu and Cu-SWCNT Nanoparticles' Suspension in Pulsatile Casson Fluid Flow via Darcy-Forchheimer Porous Channel with Compliant Walls: A Prospective Model for Blood Flow in Stenosed Arteries. Int J Mol Sci. 2021; 22(12). PMC: 8234443. DOI: 10.3390/ijms22126494. View

3.
Zhan W, Gedroyc W, Xu X . The effect of tumour size on drug transport and uptake in 3-D tumour models reconstructed from magnetic resonance images. PLoS One. 2017; 12(2):e0172276. PMC: 5315397. DOI: 10.1371/journal.pone.0172276. View

4.
Newell B, Zhan W . Mathematical modelling of microneedle-mediated transdermal delivery of drug nanocarriers into skin tissue and circulatory system. J Control Release. 2023; 360:447-467. DOI: 10.1016/j.jconrel.2023.07.011. View

5.
Bhandari A, Jaiswal K, Singh A, Zhan W . Convection-Enhanced Delivery of Antiangiogenic Drugs and Liposomal Cytotoxic Drugs to Heterogeneous Brain Tumor for Combination Therapy. Cancers (Basel). 2022; 14(17). PMC: 9454524. DOI: 10.3390/cancers14174177. View